Premarket Evidence Development

Premarket Evidence Development is a systematic process within regulatory science that generates empirical data and analytical justifications to demonstrate the safety, efficacy, and performance of a medical device prior to market authorization, distinguishing it from postmarket surveillance by focusing on pre-commercialization validation requirements under frameworks such as Investigational Device Exemptions.

10

Publications

256

Citations

43

Authors

30

Institutions

Publications per year

2017–2026

7

Authors

43

  1. RF
    Rita F. Redberg

    University of California, San Francisco, United States

    2 publications · 33 citations

    2

    h-index

  2. SS
    Sanket S. Dhruva

    University of California, San Francisco, United States

    2 publications · 33 citations

    2

    h-index

  3. JS
    Joseph S. Ross

    Yale University, United States

    1 publications · 59 citations

    1

    h-index

  4. JD
    Joshua D. Wallach

    Yale University, United States

    1 publications · 59 citations

    1

    h-index

  5. MP
    Mira Pavlovic

    University of Ferrara, Italy

    1 publications · 49 citations

    1

    h-index

1–5 of 43

Venues

  1. 2

    h-index

  2. JAMA Health Forum

    1 publications · 11 citations

    1

    h-index

  3. New England Journal of Medicine

    NEJM · 1 publications · 34 citations

    1

    h-index

  4. Expert Review of Medical Devices

    1 publications · 23 citations

    1

    h-index

  5. JAMA

    1 publications · 59 citations

    1

    h-index

1–5